tibljТуберкулез и болезни легкихTuberculosis and Lung Diseases2075-12302542-1506Медицинские знания и технологии10.58838/2075-1230-2026-104-1-80-85tiblj-1951Research ArticleКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯCLINICAL OBSERVATIONSОпыт применения клапанной бронхоблокации при полостной форме микобактериоза легких, вызванной Mycobacterium kansasii, у пациентки после эпизодов тромбоэмболии легочной артерииExperience of Using of Valve Bronchial Block for Cavitary Pulmonary Mycobacteriosis Caused by Mycobacterium Kansasii in a Patient after Episodes of Pulmonary EmbolismКуклинаГ. М.KuklinaG. M.

Куклина Галина Михайловна, к. м. н., врач-пульмонолог

127473, Москва, ул. Достоевского, д. 4, к. 2;

Тел.: +7 (495) 631-15-15

 

Galina M. Kuklina, Candidate of Medical Sciences, Pulmonologist

Build. 2 Dostoevsky St., Moscow, 127473;

Phone: +7 (495) 631-15-15

kgm74@mail.ruНаумоваТ. А.NaumovaT. A.

Наумова Татьяна Александровна, врач-эндоскопист

127473, Москва, ул. Достоевского, д. 4, к. 2;

Тел.: +7 (495) 631-15-15

Tatiana A. Naumova, Endoscopist

Build. 2 Dostoevsky St., Moscow, 127473;

Phone: +7 (495) 631-15-15

tatyana.pasynkova22@yandex.ruЕршоваН. Г.ErshovaN. G.

Ершова Наталья Германовна, к. м. н., доцент кафедры фтизиатрии ИКМ

117513, Москва, ул. Островитянова, д. 1;

Тел.: +7 (495) 434-14-22

Natalya G. Ershova, Candidate of Medical Sciences, Associate Professor of Phthisiology Department, Clinical Medicine Institute

1 Ostrovityanova St., Moscow, 117513;

Phone: +7 (495) 434-14-22

natalygerman@mail.ruhttps://orcid.org/0000-0002-3091-4677ЛовачеваО. В.LovachevaO. V.

Ловачева Ольга Викторовна, д. м. н., профессор, главный научный сотрудник отдела дифференциальной диагностики и лечения туберкулеза и сочетанных инфекций

127473, Москва, ул. Достоевского, д. 4, к. 2;

Тел.: +7 (495) 631-15-15

Olga V. Lovacheva, Doctor of Medical Sciences, Professor, Chief Researcher of Department of Differential Diagnosis and Treatment of Tuberculosis and Concurrent Infections

Build. 2 Dostoevsky St., Moscow, 127473;

Phone: +7 (495) 631-15-15

olga.lovacheva@yandex.ruФГБУ «Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных болезней» МЗ РФРоссияNational Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russian Ministry of HealthRussian FederationФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» МЗ РФРоссияPirogov Russian National Research Medical University, Russian Ministry of HealthRussian Federation20262203202610418085Copyright © Куклина Г.М., Наумова Т.А., Ершова Н.Г., Ловачева О.В., 20262026Куклина Г.М., Наумова Т.А., Ершова Н.Г., Ловачева О.В.Kuklina G.M., Naumova T.A., Ershova N.G., Lovacheva O.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.tibl-journal.com/jour/article/view/1951

Представлен клинический случай излечения микобактериоза (МБ) легких с заживлением патологической полости, возникшей в результате инвазии Mycobacterium kansasii. Сочетание индивидуально подобранной химиотерапии МБ и установки в верхнедолевой бронх правого легкого эндобронхиального клапана, дренирующего полость, позволили добиться такого результата у пациентки, имевшей в анамнезе ТЭЛА и другие локализации тромбозов, что являлось противопоказанием для резекционных операций на легком.

The article presents a clinical case of cure of pulmonary mycobacteriosis (MB) with healing of a pathological cavity that developed as a result of Mycobacterium kansasii invasion. The combination of individually selected anti-mycobacteriosis chemotherapy and implantation of an endobronchial valve in the upper lobe bronchus of the right lung, draining the cavity, made it possible to achieve this result in a patient with a history of pulmonary embolism and other localizations of thrombosis, which was a contraindication for the lung resections.

ТЭЛАмикобактериоз легкихэндобронхиальный клапанpulmonary embolismpulmonary mycobacteriosisendobronchial valveReferencesГунтупова Л.Д., Борисов С.Е., Древаль П.А. и др. Микобактериозы легких: хирургические аспекты диагностики и лечения // Туберкулез и болезни легких. – 2016. – № 5. – С. 18-26.Guntupova L.D., Borisov S.E., Dreval P.A. et al. Pulmonary mycobacterioses: surgical aspects of diagnostics and treatment. Tuberculosis and Lung Diseases, 2016, no. 5, pp. 18-26. (In Russ.)Клинические рекомендации «Туберкулез у взрослых», 2024. URL: https://cr.minzdrav.gov.ru/recomend/16_2 [Дата обращения 11.10.2025].Klinicheskie rekomendatsii Tuberkulez u vzroslykh. [Clinical guidelines on tuberculosis in adults]. 2024, Available: https://cr.minzdrav.gov.ru/recomend/16_2 Accessed October 11, 2025Ловачева О.В., Русских А.Е., Грачева А.Н., Панова А.Е., Самойлова А.Г., Васильева И.А. Лечение микобактериоза с деструкцией легких применением длительной установки эндобронхиального клапана // Туберкулез и болезни легких. –2022. – Т. 100, № 1. – С. 49-54. https://doi.org/10.21292/2075-1230-2022-100-1-49-54Lovacheva O.V., Russkikh A.E., Gracheva A.N., Panova A.E., Samoylova A.G., Vasilyeva I.A. Treatment of mycobacteriosis with lung destruction using long-term endobronchial valve implantation. Tuberculosis and Lung Diseases, 2022, vol. 100, no. 1, pp. 49-54. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-1-49-54Bents S.J., Mercaldo R.A., Powell C., Henkle E., Marras T.K., Prevots D.R. Nontuberculous mycobacterial pulmonary disease (NTM PD) incidence trends in the United States, 2010-2019 // BMC Infect Dis. – 2024. – Vol. 24, № 1. – Р. 1094. https://doi.org/10.1186/s12879-024-09965-yBents S.J., Mercaldo R.A., Powell C., Henkle E., Marras T.K., Prevots D.R. Nontuberculous mycobacterial pulmonary disease (NTM PD) incidence trends in the United States, 2010-2019. BMC Infect. Dis., 2024, vol. 24, no. 1, pp. 1094. https://doi.org/10.1186/s12879-024-09965-yCarro М.L., Herranz B.E., Royo N.R. Respiratory infections due to nontuberculous mycobacterias // Med. Clin. (Barc). – 2018. – Vol. 150, № 5. – Р. 191-197.Carro М.L., Herranz B.E., Royo N.R. Respiratory infections due to nontuberculous mycobacterias. Med. Clin. (Barc), 2018, vol. 150, no. 5, pp. 191-197.Dai J. Web-accessible database of hsp65 sequences from Mycobacterium reference strains // J. Clin. Microbiol. – 2011. – Vol. 49, № 6. – Р. 2296-2303.Dai J. Web-accessible database of hsp65 sequences from Mycobacterium reference strains. J. Clin. Microbiol., 2011, vol. 49, no. 6, pp. 2296-2303.Daley C.L., Iaccarino J.M.Р., Lange C., et al. Treatment of nontuberculous mycobacterial pulmonary disease: An Official ATS/ERS/ESCMID/IDSA clinical practice guideline // Clin. Infect. Dis. – 2020. – Vol. 71, № 4. – Р. 905-913. https://doi.org/10.1093/cid/ciaa1125Daley C.L., Iaccarino J.M.Р., Lange C. et al. Treatment of nontuberculous mycobacterial pulmonary disease: An Official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin. Infect. Dis., 2020, vol. 71, no. 4, pp. 905-913. https://doi.org/10.1093/cid/ciaa1125Daley C.L. Pulmonary non-tuberculous mycobacterial infections // Int. J. Tuberc Lung Dis. – 2010. – Vol. 14. –№ 6. – Р. 665-671.Daley C.L. Pulmonary non-tuberculous mycobacterial infections. Int. J. Tuberc. Lung Dis., 2010, vol. 14, no. 6, pp. 665-671.Griffith D.E., Aksamit T., Brown-Elliott B.A., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases // Am. J. Respir. Crit. Care Med. – 2007. – № 175. – Р. 367-416.Griffith D.E., Aksamit T., Brown-Elliott B.A. et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med., 2007, no. 175, pp. 367-416.Haworth C.S., Banks J., Capstick Т., et al. British Thoracic Society Guidelines for the Management of Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) // Thorax. – 2017. – Vol. 72, Sup l. – Р. ii1–ii64.Haworth C.S., Banks J., Capstick Т. et al. British Thoracic Society Guidelines for the Management of Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD). Thorax, 2017, vol. 72, sup l, pp. ii1– ii64.Johnson M.M.Р., Odell J.A. Nontuberculous mycobacterial pulmonary infections // J. Thorac. Dis. – 2014. – Vol. 6, № 3. – Р. 210-219.Johnson M.M.Р., Odell J.A. Nontuberculous mycobacterial pulmonary infections. J. Thorac. Dis., 2014, vol. 6, no. 3, pp. 210-219.Johnson T.M., Byrd T.F., Drummond W.K., et al. Contemporary Pharmacotherapies for nontuberculosis mycobacterial infections: a narrative review // Infect. Dis. Ther. – 2023. – https://doi.org/10.1007/s40121-022-00750-5Johnson T.M., Byrd T.F., Drummond W.K. et al. Contemporary pharmacotherapies for nontuberculosis mycobacterial infections: a narrative review. Infect. Dis., Ther., 2023. https://doi.org/10.1007/s40121-022-00750-5Kim J-Y., Lee H.W., Yim J-J., Kwak N. Outcomes of adjunctive surgery in patients with nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis // Chest. – Vol. 163, № 4. – Р. 763-777. https://doi.org/10.1016/j.chest.2022.09.037Kim J-Y., Lee H.W., Yim J-J., Kwak N. Outcomes of adjunctive surgery in patients with nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis. Chest, vol. 163, no. 4, pp. 763-777. https://doi.org/10.1016/j.chest.2022.09.037Koh W.J., Jeong B.H., Kim S.Y., et al. Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease // Clin Infect Dis. – 2017. – Vol. 64, № 3. – Р. 309-316.Koh W.J., Jeong B.H., Kim S.Y. et al. Mycobacterial characteristics and treatment outcomes in Mycobacterium abscessus lung disease. Clin. Infect. Dis., 2017, vol. 64, no. 3, pp. 309-316.Koh W.J., Moon S.M., Kim S.Y., et al. Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype // Eur Respir J. – 2017. – Vol. 50, № 3. – Р. 1602503.Koh W.J., Moon S.M., Kim S.Y. et al. Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype. Eur. Respir. J., 2017, vol. 50, no. 3, pp. 1602503.Ku J.H., Henkle E., Aksamit T.R. Treatment of Nontuberculous Mycobacterial (NTM) pulmonary infection in the US bronchiectasis and NTM registry: treatment patterns, adverse events, and adherence to American Thoracic Society / Infectious Disease Society of America Clin Infect Dis // 2023. – Vol. 76, № 2. – Р. 338-341. https://doi.org/10.1093/cid/ciac788Ku J.H., Henkle E., Aksamit T.R. Treatment of nontuberculous mycobacterial (NTM) pulmonary infection in the US bronchiectasis and NTM registry: treatment patterns, adverse events, and adherence to American Thoracic Society. Infectious Disease Society of America. Clin. Infect. Dis., 2023, vol. 76, no. 2, pp. 338-341. https://doi.org/10.1093/cid/ciac788Nontuberculous Mycobacteriosis Control Committee of the Japanese Society for Tuberculosis; International Exchanging Committee of the Japanese Society for Tuberculosis. Guidelines for surgical therapy for pulmonary nontuberculous mycobacterial diseases // Kekkaku. – 2011. – Vol. 86, № 1. – Р. 41-42.Nontuberculous Mycobacteriosis Control Committee of the Japanese Society for Tuberculosis; International Exchanging Committee of the Japanese Society for Tuberculosis. Guidelines for surgical therapy for pulmonary nontuberculous mycobacterial diseases. Kekkaku, 2011, vol. 86, no. 1, pp. 41-42.Pathak K., Hart S., Lande L. Nontuberculous Mycobacteria Lung Disease (TM-LD): Current Recommendations on Diagnosis, Treatment, and Patient Management // Int J Gen Med. – 2022. – № 15. – Р. 7619-7629. https://doi.org/10.2147/IJGM.S272690Pathak K., Hart S., Lande L. Nontuberculous Mycobacteria Lung Disease (TM-LD): Current Recommendations on Diagnosis, Treatment, and Patient Management. Int. J. Gen. Med., 2022, no. 15, pp. 7619-7629. https://doi.org/10.2147/IJGM.S272690Sherwood J.T., Mitchell J.D., Pomerantz M. Completion pneumonectomy for chronic mycobacterial disease // J. Thorac. Cardiovasc. Surg. – 2005. – Vol. 129, № 6. – Р. 1258-1265.Sherwood J.T., Mitchell J.D., Pomerantz M. Completion pneumonectomy for chronic mycobacterial disease. J. Thorac. Cardiovasc. Surg., 2005, vol. 129, no. 6, pp. 1258-1265.Shiraishi Y., Nakajima Y., Katsuragi N., et al. Pneumonectomy for nontuberculous mycobacterial infections // Ann. Thorac. Surg. – 2004. – Vol. 78, № 2. – Р. 399-403.Shiraishi Y., Nakajima Y., Katsuragi N. et al. Pneumonectomy for nontuberculous mycobacterial infections. Ann. Thorac. Surg., 2004, vol. 78, no. 2, pp. 399-403.Treatment Guidelines. For the Bronchiectasis and NTM Research Registry investigators // Clin. Infect. Dis. – 2023. – Vol. 76, № 2. – Р. 338-341. https://doi.org/10.1093/cid/ciac788Treatment Guidelines. For the bronchiectasis and NTM Research Registry investigators. Clin. Infect. Dis., 2023, vol. 76, no. 2, pp. 338-341. https://doi.org/10.1093/cid/ciac788Wallace R.J.Jr., Zhang Y., Brown-Elliott B.A., et al. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis // J Infect Dis. – 2002. – Vol. 186, № 2. – Р. 266-273.Wallace R.J.Jr., Zhang Y., Brown-Elliott B.A. et al. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis. J. Infect. Dis., 2002, vol. 186, no. 2, pp. 266-273.

The authors declare that there are no conflicts of interest present.